Clinical Trial Update: Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating venetoclax in combination with a CACAG regimen versus the 3+7 regimen for acute monocytic leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Monocytic Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Venetoclax (venetoclax)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Acute Monocytic Leukemia | Phase 2 | Status: RECRUITING